Evidence map›Paper›PMID 27029580›Full record

ArticleVirulence2016

Identification of the pXO1 plasmid in attenuated Bacillus anthracis vaccine strains.

Xudong Liang, Huijuan Zhang, Enmin Zhang, Jianchun Wei, Wei Li, Bingxiang Wang, Shulin Dong, Jin Zhu

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Genome sequences of twoMicrobiology resource announcements · 2024
    Article
  3. New Research on thePathogens (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. TheFrontiers in cellular and infection microbiology · 2017
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Xudong Lianga National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control , Beijing , China.
Huijuan Zhanga National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control , Beijing , China.
Enmin Zhanga National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control , Beijing , China.
Jianchun Weia National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control , Beijing , China.
Wei Lia National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control , Beijing , China.
Bingxiang Wangb Lanzhou Institute of Biological Products Co., Ltd , Lanzhou , China.
Shulin Dongb Lanzhou Institute of Biological Products Co., Ltd , Lanzhou , China.
Jin Zhuc Huadong Medical Institute of Biotechniques , Nanjing , China.
National Institute for Communicable Disease Control and Prevention · CNLanzhou Institute of Husbandry and Pharmaceutical Sciences · CNState Key Laboratory of Infectious Disease Prevention and ControlHuadong Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthrax toxins and capsule are the major virulence factors of Bacillus anthracis. They are encoded by genes located on the plasmids pXO1 and pXO2, respectively. The vaccine strain Pasteur II was produced from high temperature subcultures of B. anthracis, which resulted in virulence attenuation through the loss of the plasmid pXO1. However, it is unclear whether the high temperature culture completely abolishes the plasmid DNA or affects the replication of the plasmid pXO1. In this study, we tested 3 B. anthracis vaccine strains, including Pasteur II from France, Qiankefusiji II from Russia, and Rentian II from Japan, which were all generated from subcultures at high temperatures. Surprisingly, we detected the presence of pXO1 plasmid DNA using overlap PCR in all these vaccine strains. DNA sequencing analysis of overlap PCR products further confirmed the presence of pXO1. Moreover, the expression of the protective antigen (PA) encoded on pXO1 was determined by using SDS-PAGE and western blotting. In addition, we mimicked Pasteur's method and exposed the A16R vaccine strain, which lacks the pXO2 plasmid, to high temperature, and identified the pXO1 plasmid in the subcultures at high temperatures. This indicated that the high temperature treatment at 42.5°C was unable to eliminate pXO1 plasmid DNA from B. anthracis. Our results suggest that the attenuation of the Pasteur II vaccine strain is likely due to the impact of high temperature stress on plasmid replication, which in turn limits the copy number of pXO1. Our data provide new insights into the mechanisms of the remaining immunogenicity and toxicity of the vaccine strains.

Indexed as

PlasmidsAnthrax VaccinesAntigens, BacterialBacillus anthracisBacterial ToxinsDNA, BacterialHot TemperatureImmunogenicity, VaccinePolymerase Chain ReactionVaccines, AttenuatedVirulenceVirulence Factorsanthrax toxinAnthrax VaccinesAntigens, BacterialBacterial ToxinsDNA, BacterialVaccines, AttenuatedVirulence Factorsattenuatedbacillus anthracispXO1 plasmidvaccine strains

Identifiers

PMID27029580
PMCPMC5026784
OpenAlexW2335720438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.